3 results on atopic dermatitis
Approved WMORecruiting
The objective of the study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult subjects with moderate to severe AD who are candidates for systemic therapy.
Approved WMORecruiting
The objective of the study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of adolescent and adult subjects with moderate to severe AD who are candidates for systemic therapy.
Approved WMOPending
The primary objective of this study is to assess whether tacrolimus is effective for the treatment of morphea.